Wat is de prijs voor BIOLASE, Inc. (BIOL)

Het prijs van BIOLASE, Inc. (BIOL) is $0.00695

Wat is de marktkapitalisatie voor BIOLASE, Inc. (BIOL)

Marktkapitalisatie voorBIOLASE, Inc. (BIOL) is $536.40

BIOLASE, Inc. (BIOL) Aandelensplitsingen

BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.

Jaar	Splitsing	Vermenigvuldiging	Cumulatieve vermenigvuldiging
2023-07-28	1:100	x0.01	x2.0E-5
2022-04-29	1:25	x0.04	x0.002
2018-05-11	1:5	x0.2	x0.05
1994-02-15	1:4	x0.25	x0.25

Jaar

Splitsing

Vermenigvuldiging

Cumulatieve vermenigvuldiging

2023-07-28

1:100

x0.01

x2.0E-5

2022-04-29

1:25

x0.04

x0.002

2018-05-11

1:5

x0.2

x0.05

1994-02-15

1:4

x0.25

Bedrijf	Aantal aandelen splitsingen	Cumulatieve vermenigvuldiging	Land
Abbott Laboratories ABT.US	9	x285	US
Stryker Corporation SYK.US	9	x162	US
Medtronic plc MDT.US	7	x127	IE
Boston Scientific Corporation BSX.US	2	x4	US
Edwards Lifesciences Corporation EW.US	3	x12	US

Bedrijf

Aantal aandelen splitsingen

Cumulatieve vermenigvuldiging

Land